Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke PreventionBusiness Wire • 01/27/26
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 01/26/26
Bayer Aktiengesellschaft (BAYRY) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 01/22/26
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup CaseZacks Investment Research • 01/20/26
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney DiseasesBusiness Wire • 01/20/26
Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuitsNew York Post • 01/16/26
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigationBusiness Wire • 01/16/26
Bayer Aktiengesellschaft (BAYRY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn't Stop for a Hot Flash' Campaign for Moderate to Severe Hot Flashes Due to MenopauseBusiness Wire • 01/13/26
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From AttralusBusiness Wire • 01/12/26
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline ProgressZacks Investment Research • 01/09/26
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA TherapyBusiness Wire • 01/08/26
Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan's 44th Annual Healthcare ConferenceBusiness Wire • 01/05/26